Abstract
This letter describes the discovery of a fused benzofuran scaffold viable for preparing a series of novel potent HCV NS5B polymerase non-nucleoside inhibitors. Designed on the basis of the functionalized benzofuran derivative nesbuvir (HCV-796), these compounds presumably bind similarly to the allosteric binding site in the "palm" domain of HCV NS5B protein. SAR of each potential hydrogen-bonding interaction site of this novel scaffold is discussed along with some preliminary genotypic profile and PK data of several advanced compounds.
Keywords:
Fused benzofuran; HCV; NS5B polymerase; Non-nucleoside inhibitor.
Copyright © 2018 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
Antiviral Agents / chemical synthesis
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Benzofurans / chemical synthesis
-
Benzofurans / chemistry
-
Benzofurans / pharmacology*
-
Cell Line, Tumor
-
Dose-Response Relationship, Drug
-
Drug Discovery*
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology*
-
HIV / drug effects*
-
Humans
-
Microbial Sensitivity Tests
-
Molecular Structure
-
Rats
-
Structure-Activity Relationship
-
Viral Nonstructural Proteins / antagonists & inhibitors*
Substances
-
Antiviral Agents
-
Benzofurans
-
Enzyme Inhibitors
-
Viral Nonstructural Proteins
-
NS-5 protein, hepatitis C virus
-
benzofuran